MoneyBloomberg Markets
City Therapeutics Raises $200 Million in Upsized US IPO
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
Join the argument
House rules →Comments load as you scroll.